Agilent Technologies Property, Plant, and Equipment 2010-2025 | A
Agilent Technologies property, plant, and equipment from 2010 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Agilent Technologies property, plant, and equipment for the quarter ending April 30, 2025 was $1.816B, a 38.2% increase year-over-year.
- Agilent Technologies property, plant, and equipment for 2024 was $1.778B, a 40% increase from 2023.
- Agilent Technologies property, plant, and equipment for 2023 was $1.27B, a 15.45% increase from 2022.
- Agilent Technologies property, plant, and equipment for 2022 was $1.1B, a 16.4% increase from 2021.
| Agilent Technologies Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2024 | $1,778 |
| 2023 | $1,270 |
| 2022 | $1,100 |
| 2021 | $945 |
| 2020 | $845 |
| 2019 | $850 |
| 2018 | $822 |
| 2017 | $757 |
| 2016 | $639 |
| 2015 | $604 |
| 2014 | $631 |
| 2013 | $1,134 |
| 2012 | $1,164 |
| 2011 | $1,006 |
| 2010 | $980 |
| 2009 | $845 |
| Agilent Technologies Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2025-01-31 | $1,816 |
| 2024-10-31 | $1,778 |
| 2024-07-31 | $1,446 |
| 2024-04-30 | $1,371 |
| 2024-01-31 | $1,314 |
| 2023-10-31 | $1,270 |
| 2023-07-31 | $1,211 |
| 2023-04-30 | $1,184 |
| 2023-01-31 | $1,147 |
| 2022-10-31 | $1,100 |
| 2022-07-31 | $1,054 |
| 2022-04-30 | $1,010 |
| 2022-01-31 | $974 |
| 2021-10-31 | $945 |
| 2021-07-31 | $905 |
| 2021-04-30 | $884 |
| 2021-01-31 | $866 |
| 2020-10-31 | $845 |
| 2020-07-31 | $846 |
| 2020-04-30 | $836 |
| 2020-01-31 | $844 |
| 2019-10-31 | $850 |
| 2019-07-31 | $839 |
| 2019-04-30 | $827 |
| 2019-01-31 | $829 |
| 2018-10-31 | $822 |
| 2018-07-31 | $801 |
| 2018-04-30 | $798 |
| 2018-01-31 | $792 |
| 2017-10-31 | $757 |
| 2017-07-31 | $716 |
| 2017-04-30 | $675 |
| 2017-01-31 | $653 |
| 2016-10-31 | $639 |
| 2016-07-31 | $623 |
| 2016-04-30 | $610 |
| 2016-01-31 | $594 |
| 2015-10-31 | $604 |
| 2015-07-31 | $587 |
| 2015-04-30 | $593 |
| 2015-01-31 | $610 |
| 2014-10-31 | $631 |
| 2014-07-31 | $1,142 |
| 2014-04-30 | $1,139 |
| 2014-01-31 | $1,129 |
| 2013-10-31 | $1,134 |
| 2013-07-31 | $1,139 |
| 2013-04-30 | $1,147 |
| 2013-01-31 | $1,163 |
| 2012-10-31 | $1,164 |
| 2012-07-31 | $1,139 |
| 2012-04-30 | $996 |
| 2012-01-31 | $1,007 |
| 2011-10-31 | $1,006 |
| 2011-07-31 | $1,000 |
| 2011-04-30 | $1,004 |
| 2011-01-31 | $982 |
| 2010-10-31 | $980 |
| 2010-07-31 | $957 |
| 2010-04-30 | $831 |
| 2010-01-31 | $837 |
| 2009-10-31 | $845 |
| 2009-07-31 | $839 |
| 2009-04-30 | $821 |
| 2009-01-31 | $831 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $33.778B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.401B | 28.55 |
| Boston Scientific (BSX) | United States | $145.814B | 36.50 |
| Stryker (SYK) | United States | $145.229B | 30.37 |
| EssilorLuxottica (ESLOY) | France | $130.605B | 0.00 |
| Medtronic (MDT) | Ireland | $113.492B | 16.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.916B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.556B | 28.23 |
| ResMed (RMD) | United States | $36.981B | 27.78 |
| GE HealthCare Technologies (GEHC) | United States | $33.476B | 15.89 |
| Terumo (TRUMY) | Japan | $27.213B | 35.35 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.367B | 83.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.85 |
| Baxter (BAX) | United States | $16.093B | 12.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.187B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.325B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 13.99 |
| Prestige Consumer Healthcare (PBH) | United States | $4.207B | 18.80 |
| Perrigo (PRGO) | Ireland | $3.746B | 9.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.428B | 15.61 |
| ICU Medical (ICUI) | United States | $3.258B | 24.02 |
| Envista Holdings (NVST) | United States | $3.198B | 26.58 |
| GN Store Nord (GNNDY) | Denmark | $2.319B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.021B | 13.90 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.10 |
| AtriCure (ATRC) | United States | $1.600B | 0.00 |
| Acuren (TIC) | United States | $1.308B | 0.00 |
| Neogen (NEOG) | United States | $1.220B | 15.61 |
| AdaptHealth (AHCO) | United States | $1.187B | 12.05 |
| BioLife Solutions (BLFS) | United States | $1.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.061B | 23.86 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.963B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 8.95 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.656B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.637B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.576B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.419B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.92 |
| Aurora Cannabis (ACB) | Canada | $0.342B | 60.90 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.60 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanara MedTech (SMTI) | United States | $0.255B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.08 |
| Brainsway (BWAY) | Israel | $0.216B | 57.10 |
| TriSalus Life Sciences (TLSI) | United States | $0.208B | 0.00 |
| Omeros (OMER) | United States | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.51 |
| Jin Medical (ZJYL) | China | $0.109B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.29 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |